These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35932129)

  • 1. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease.
    Bai B; Ya JL; Yan C
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1037-1041. PubMed ID: 35932129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive potential of age-group cut-off values of N-terminal pro-brain natriuretic peptide in Kawasaki disease.
    Hirai S; Nakamura T; Misawa M
    Pediatr Int; 2022 Jan; 64(1):e15371. PubMed ID: 36166642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.
    Song HB; Zhang YD; Dong QW; Han LP; Qi RF; Bi BB; Ma L; Ma L; Zhang H
    J Coll Physicians Surg Pak; 2020 Jan; 30(1):37-40. PubMed ID: 31931930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease.
    Lu Y; Guo Y; Si F; Chen T; Jin M; Wen Y; Wang X
    Sci Rep; 2020 Jun; 10(1):10211. PubMed ID: 32576944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease.
    Zheng X; Zhang Y; Liu L; Yue P; Wang C; Zhou K; Hua Y; Wu G; Li Y
    Sci Rep; 2020 Mar; 10(1):5130. PubMed ID: 32198398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M
    Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
    Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
    Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
    Kaneko K; Yoshimura K; Ohashi A; Kimata T; Shimo T; Tsuji S
    Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease.
    Cai WJ; Ding SG
    Medicine (Baltimore); 2022 Dec; 101(52):e32430. PubMed ID: 36596080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
    Zhang H; Zhang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):461-468. PubMed ID: 38802905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY; Ham EM; Kwon H; Kwak YH; Kim DK; Lee JH; Jung JH
    Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Clinical Evaluation of Coronary Artery Lesions in Kawasaki Disease.
    Shu Z; Deng F; Yang S
    Clin Pediatr (Phila); 2024 Oct; 63(9):1287-1291. PubMed ID: 38135926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease].
    Chen TT; Shi K; Liu YL; Guo YH; Li Y; Wang XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial work is independent risk factor for coronary artery lesions in children with Kawasaki disease.
    Tang G; Zheng X; Liu K; Yu F; Zhang J
    Coron Artery Dis; 2024 Mar; 35(2):149-155. PubMed ID: 38088792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J; Jiang H; Lu M
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan.
    Suzuki T; Kakimoto N; Tsuchihashi T; Suenaga T; Takeuchi T; Shibuta S; Kitano N; Suzuki H
    Eur J Pediatr; 2021 Sep; 180(9):2797-2805. PubMed ID: 33763715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.